跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TADALAFILO ALTER 5 MG COMPRIMIDOS BUCODISPERSABLES EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TADALAFILO ALTER 5 MG COMPRIMIDOS BUCODISPERSABLES EFG
Approved
STANDARD
TADALAFILO ALTER 5 MG COMPRIMIDOS BUCODISPERSABLES EFG
Laboratorios Alter S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 7, 2024
Approval ID
b50f602668c7767f
Company
Laboratorios Alter S.A.
Type
Standard
Approval Details
Approval Id
b50f602668c7767f
Drug Cima Aemps Name
TADALAFILO ALTER 5 MG COMPRIMIDOS BUCODISPERSABLES EFG
Register Number
89623
Holder Company Name
Laboratorios Alter S.A.
Marketing Company Name
Laboratorios Alter S.A.
Authorization Date
2024-06-07
Dosage Form
COMPRIMIDO BUCODISPERSABLE
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Alter S.A.
Active Ingredients
TADALAFILO
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 7, 2024
Approval ID
b50f602668c7767f
Type
Standard
Back to CIMA-AEMPS Approvals